The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
Brad Smith explores the topics most important to your wallet on Wealth. Compass realtor Melanie Atkinson discusses the ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.